ARCHIVES

FDA Designates Zometa For Priority Review.

This article is from The Cancer Letter archive.

Vol. 27 No. 44 | November 30, 2001

Download PDF Visit The Full Archive

Related Articles

NIH wins A-76 competition for extramural support services.

September 26, 2003

Rep. Bliley Challenges FDA On Failure To Approve Oral Colon Cancer Drug UFT.

April 21, 2000

Lung Cancer Survivors Claim Good QOL, Despite Challenges

August 30, 2002

Oblimersen Combination Improves CLL Survival

December 28, 2007

Fogarty Leads Grant Program On World Tobacco Research.

July 6, 2001

FDA’s Handling Of UFT Raises Questions About Agency’s Isolation, Grasp Of Science.

July 21, 2000